KIORA PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
KIORA PHARMACEUTICALS, INC. (KPRX) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $1.66 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-23.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2017-02-23
- KIORA PHARMACEUTICALS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2015-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2015-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2015-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2015-03-31 was $1.66M.
- KIORA PHARMACEUTICALS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2015 was $1.66M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $1.66M 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $1.66M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $1.66M 10-Q · filed 2015-08-12 | ||
| 2015-03-31 | $1.66M 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |